Kissei Pharmaceutical Co., Ltd. (4547) Press Release
Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]
Earlier from Kissei Pharmaceutical
- Notice Regarding Completion of Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers
- Announcement for the Opnion by European Authorities on TAVNEOS
- Notice Concerning Status of Acquisition of Treasury Shares
- Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment